血管内透明质酸填充剂注射后部分可逆性失明。

IF 1.5 Q3 SURGERY

Plastic and Reconstructive Surgery Global Open Pub Date : 2024-11-20 eCollection Date: 2024-11-01 DOI:10.1097/GOX.0000000000006316

Patricia Barrera, Gillian Murray, Alejandra Pantano

{"title":"血管内透明质酸填充剂注射后部分可逆性失明。","authors":"Patricia Barrera, Gillian Murray, Alejandra Pantano","doi":"10.1097/GOX.0000000000006316","DOIUrl":null,"url":null,"abstract":"Blindness from hyaluronic acid filler injections is an uncommon but devastating complication. We present a case of blindness related to a \"skin booster.\" It is often assumed that skin boosters have no risk of visual problems, and this case underlines the need to understand products' rheology and chemistry. Given the lack of agreed consensus in bedside and secondary care management, it is important to report and describe all cases of vision loss caused by fillers, including assessment and management, to allow understanding of what may give rise to better outcomes.","PeriodicalId":20149,"journal":{"name":"Plastic and Reconstructive Surgery Global Open","volume":"12 11","pages":"e6316"},"PeriodicalIF":1.5000,"publicationDate":"2024-11-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11578212/pdf/","citationCount":"0","resultStr":"{\"title\":\"Partially Reversible Episode of Blindness after Intravascular Hyaluronic Acid Filler Injection.\",\"authors\":\"Patricia Barrera, Gillian Murray, Alejandra Pantano\",\"doi\":\"10.1097/GOX.0000000000006316\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Blindness from hyaluronic acid filler injections is an uncommon but devastating complication. We present a case of blindness related to a \\\"skin booster.\\\" It is often assumed that skin boosters have no risk of visual problems, and this case underlines the need to understand products' rheology and chemistry. Given the lack of agreed consensus in bedside and secondary care management, it is important to report and describe all cases of vision loss caused by fillers, including assessment and management, to allow understanding of what may give rise to better outcomes.\",\"PeriodicalId\":20149,\"journal\":{\"name\":\"Plastic and Reconstructive Surgery Global Open\",\"volume\":\"12 11\",\"pages\":\"e6316\"},\"PeriodicalIF\":1.5000,\"publicationDate\":\"2024-11-20\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11578212/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Plastic and Reconstructive Surgery Global Open\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1097/GOX.0000000000006316\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/11/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q3\",\"JCRName\":\"SURGERY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Plastic and Reconstructive Surgery Global Open","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1097/GOX.0000000000006316","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/11/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"SURGERY","Score":null,"Total":0}

引用次数: 0

摘要

透明质酸填充剂注射致盲是一种不常见但却具有破坏性的并发症。我们介绍了一例与 "皮肤增效剂 "有关的失明病例。人们通常认为皮肤增效剂没有视觉问题的风险，本病例强调了了解产品流变学和化学性质的必要性。鉴于在床旁和二级护理管理方面缺乏一致的共识，因此报告和描述所有因填充剂导致视力下降的病例（包括评估和管理）非常重要，以便了解哪些因素可能会带来更好的结果。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Partially Reversible Episode of Blindness after Intravascular Hyaluronic Acid Filler Injection.

Blindness from hyaluronic acid filler injections is an uncommon but devastating complication. We present a case of blindness related to a "skin booster." It is often assumed that skin boosters have no risk of visual problems, and this case underlines the need to understand products' rheology and chemistry. Given the lack of agreed consensus in bedside and secondary care management, it is important to report and describe all cases of vision loss caused by fillers, including assessment and management, to allow understanding of what may give rise to better outcomes.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Plastic and Reconstructive Surgery Global Open SURGERY-

CiteScore

2.20

自引率

13.30%

发文量

1584

审稿时长

10 weeks

期刊介绍： Plastic and Reconstructive Surgery—Global Open is an open access, peer reviewed, international journal focusing on global plastic and reconstructive surgery.Plastic and Reconstructive Surgery—Global Open publishes on all areas of plastic and reconstructive surgery, including basic science/experimental studies pertinent to the field and also clinical articles on such topics as: breast reconstruction, head and neck surgery, pediatric and craniofacial surgery, hand and microsurgery, wound healing, and cosmetic and aesthetic surgery. Clinical studies, experimental articles, ideas and innovations, and techniques and case reports are all welcome article types. Manuscript submission is open to all surgeons, researchers, and other health care providers world-wide who wish to communicate their research results on topics related to plastic and reconstructive surgery. Furthermore, Plastic and Reconstructive Surgery—Global Open, a complimentary journal to Plastic and Reconstructive Surgery, provides an open access venue for the publication of those research studies sponsored by private and public funding agencies that require open access publication of study results. Its mission is to disseminate high quality, peer reviewed research in plastic and reconstructive surgery to the widest possible global audience, through an open access platform. As an open access journal, Plastic and Reconstructive Surgery—Global Open offers its content for free to any viewer. Authors of articles retain their copyright to the materials published. Additionally, Plastic and Reconstructive Surgery—Global Open provides rapid review and publication of accepted papers.